Tradestie Institutional Equity Comparison Engine
BMED vs LSAF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LSAF Overall Edge
LSAF Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to LeaderShares AlphaFactor US Core Equity ETF (LSAF) driven by superior Momentum & Technical while BMED counters with relative strength in Options & Structure. Fundamentally, BMED trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus LSAF at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BMED sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against LSAF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BMED N/M vs LSAF N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
LSAF
1Y +26.3% vs +29.0% ยท 52W Pos 86% vs 90%
Options & Structure Winner
BMED
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (N/A IV)
BMED
NYSE Arca
iShares Health Innovation Active ETF
Institutional Equity
$35.93
-1.06% 1D
Market Cap
N/A
1M Return
+3.99%
1Y Return
+26.28%
Forward P/E
N/M
Unified AI Score
51.8 / 100
HOLD
Tech 44.0
Fund 44.0
Flow 50.0
Mom 41.6
LSAF
NYSE Arca
LeaderShares AlphaFactor US Core Equity ETF
Institutional Equity
$57.26
-1.02% 1D
Market Cap
N/A
1M Return
+2.39%
1Y Return
+28.99%
Forward P/E
N/M
Unified AI Score
47.0 / 100
HOLD
Tech 40.0
Fund 44.0
Flow 50.0
Mom 41.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BMED +26.28%
LSAF +28.99%
Spread: +5.32 pp (LSAF Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BMED TTM Op. Margin: N/A
LSAF TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BMED vs LSAF. Trailing 12-month operating profitability (BMED N/A vs LSAF N/A) and valuation multiples (BMED N/M vs LSAF N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BMED | LSAF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 86% ($27โ$37) | 90% ($42โ$59) | Stronger Trend | LSAF |
| Beta / 30D Volatility Risk Regime | 0.61ฮฒ ยท 24% Vol | 0.62ฮฒ ยท 19% Vol | Lower Realized Risk | LSAF |
| Unified Institutional Score Composite Signal | 51.8 / 100 (HOLD) | 47.0 / 100 (HOLD) | Higher Composite | BMED |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BMED vs LSAF Buy Guide
BMED
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
LSAF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BMED nor LSAF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.